Make sense of the report

Start with what changed from your baseline and what each marker actually measures. Testosterone, blood count, cholesterol and fertility can tell different stories; one normal number is not an all-clear.

A flag is a reason to review the result, not an automatic instruction to add an AI or donate blood. Keep the units, reference range and dose timing beside the number.

Find a marker Check blood-draw timing

Keep the whole report

A number needs context

Test + result
Total and free testosterone are different measurements.
Units + range
Use that laboratory's units and reference interval.
Sampling time
Record time since the last dose and recent changes.
Your earlier results
Compare the trend alongside symptoms.
A high or low flag starts a review. It does not automatically choose a medicine or a dose.

New chest pain, trouble breathing, stroke-like symptoms or severe illness need urgent care rather than online lab interpretation.

What the main markers tell you

Hormone picture

Total testosterone
Circulating testosterone at this sampling time. Does not quantify every synthetic androgen in a stack.
Free testosterone + SHBG
How hormone binding affects interpretation. The assay or calculation method matters.
LH + FSH
The pituitary signaling pattern. Treatment and recent suppression change the context.
Estradiol
A result to assess alongside symptoms and treatment. The number alone does not select an AI.

Blood count and other effects

Hemoglobin + hematocrit
Whether red-cell concentration has changed. Cause and trend matter; this is not a performance target.
Lipids
Changes in cholesterol and cardiovascular risk markers. Normal liver tests do not clear the lipid panel.
Liver panel
Findings needing liver or other investigation. AST and ALT can also rise after muscle injury or hard exercise.

Testosterone diagnosis requires symptoms and consistently low, appropriately measured results. Follow-up during treatment answers a different question from diagnosis before treatment. Endocrine Society guidance

Read a result in this order

  1. Check the report

    Confirm test name, units, laboratory and reference interval.

  2. Place it on the timeline

    Record dose timing, recent changes, illness and hard exercise.

  3. Compare with earlier results

    Look for a pattern rather than a single red flag.

  4. Connect it to a clinical question

    Hormone exposure, fertility, blood count and cardiovascular risk are different questions.

There is no universal trough rule

For prescribed enanthate or cypionate, the Endocrine Society’s monitoring table describes measuring testosterone midway between injections. For long-acting injectable undecanoate, it describes sampling near the end of the interval. Some product labels specify a different measurement approach; AndroGel 1.62% uses a pre-dose morning value for titration. Monitoring table; AndroGel label.

Follow the plan for the actual product and clinical question. If the sampling point changes, record it before comparing results.

Hematocrit is an action point, not an internet target

TRT guidance calls for clinician action when hematocrit exceeds 54%, including evaluating contributors such as hypoxia and sleep apnea. That threshold is a monitoring rule in prescribed therapy, not proof that 53.9% is safe for every person or every steroid exposure. Do not assume blood donation alone resolves the cause. Guideline hematocrit monitoring

A liver-enzyme rise needs the surrounding information

A study in men unaccustomed to weightlifting found that strenuous lifting raised AST, ALT and muscle-injury markers for at least a week. This is a reason to tell the clinician about training—not a reason to dismiss abnormal results as “just the gym.” Bilirubin, other tests, symptoms and the exposure history may change the interpretation. Pettersson et al., 2008

Jaundice, dark urine or substantial abdominal pain need prompt assessment. Do not wait for a routine repeat merely to obtain a cleaner-looking result.

PSA and prostate monitoring

PSA interpretation depends on age, risk, baseline, symptoms and shared decisions about screening. A single universal PSA cutoff cannot replace that context. The testosterone guideline recommends confirmation and clinical evaluation of specified rises during treatment; it does not diagnose cancer from one value.

Common questions

Can I compare the plotter directly with total testosterone? Not when the plot shows only the injected-drug contribution. Endogenous production is missing from that output.

Does normal testosterone mean fertility is normal? No. Semen assessment answers a different question.

Does an elevated estradiol result mean I need an AI? No automatic treatment follows. See AI timing.

What should I bring to an appointment? The full report, previous results, actual product details, dose dates and a short symptom timeline—not just the flagged numbers.

Sources and what they apply to

Checked October 12, 2026. The Endocrine Society guideline provides treatment-monitoring guidance for diagnosed testosterone deficiency. The exercise study shows one reason AST and ALT can rise outside primary liver disease; it does not explain away an individual abnormal result. Prescribed-treatment rules are not a clearance to continue nonmedical AAS use.